Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery

Nicolai Huebner, Sazan Rasul, Pascal Baltzer, Paola Clauser, Karl Hermann Grubmüller, Markus Mitterhauser, Marcus Hacker, Axel Heidenreich, Pawel Rajwa, Harun Fajkovic, Shahrokh F Shariat, Bernhard Grubmüller

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

2 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry